Profile
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB. Leanderson earned a doctorate degree from Umea Universitet.
Tomas Leanderson active positions
| Companies | Position | Start |
|---|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2010-05-05 |
Former positions of Tomas Leanderson
| Companies | Position | End |
|---|---|---|
| ACTIVE BIOTECH AB | Chief Executive Officer | 2017-06-30 |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Director/Board Member | - |
Training of Tomas Leanderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
- Stock Market
- Insiders
- Tomas Leanderson
















